Product/Composition:- | Sorafenib |
---|---|
Strength:- | 200 mg |
Form:- | Tablet |
Reference Brands:- | Nexavar® (US & EU) |
MOQ | As per the manufacturer batch size |
Get Quote Send Enquiry on WhatsApp |
Sorafenib is an oral kinase inhibitor used to treat advanced liver cancer (HCC), renal cell carcinoma (RCC), and thyroid cancer. Available in 200 mg tablets under the brand Nexavar® in the US and EU, it blocks tumor cell growth and angiogenesis. Ideal for B2B pharma distributors.
Sorafenib is a targeted therapy used in the treatment of advanced liver cancer (HCC), renal cell carcinoma (RCC), and thyroid cancer. As an oral kinase inhibitor, it works by blocking tumor cell proliferation and angiogenesis. Available under the brand name Nexavar®, it is marketed in 200 mg tablets in both the US and EU. Sorafenib is a critical component in the treatment of various solid tumors and is manufactured under GMP-compliant standards. Ideal for B2B pharmaceutical partners, it is supplied globally for oncology distributors and hospital tender markets seeking reliable oncology treatments.
Embrace a platform that empowers you to invest in gold online effortlessly, making the path to financial growth accessible to everyone.
Get access to the finest pharmacy products with a NazarethPharmacy.com. They offer comprehensive worldwide pharmacy services, making them your best choice for online medications